Tracey Roizman

A retrospective analysis finds that patients who undergo pneumonectomy or are aged 70 years or older after receiving neoadjuvant concurrent chemoradiation therapy experience less favorable surgical outcomes. Lung cancer, particularly stage IIIA–N2 non-small cell lung cancer (NSCLC), is one of the leading causes of cancer-related deaths worldwide. The most effective treatment approach for this type...

Neoadjuvant chemoimmunotherapy, whether compared to immunotherapy alone or in combination with apatinib, may lead to increased surgical complexity while maintaining an acceptable incidence of postoperative complications, according to the results of a retrospective study. Lung cancer, specifically non-small cell lung cancer (NSCLC), is the leading cause of cancer-related deaths worldwide, accounting for nearly 85% of...

In a retrospective study, patients without a social support network had a shorter survival rate than those with support. Non-small cell lung cancer (NSCLC) continues to be a significant health issue and is a leading cause of death in many countries. Although there are promising new treatments available for certain types of lung cancer, managing...

A cohort study finds that class-switched B cells could potentially be used as a prognostic marker for non-small cell lung cancer and as a target for future therapeutic strategies. Lung cancer is a major global health concern. Significant progress has been made in treatment, with immunotherapy emerging as a recent breakthrough of great promise. The...

Nonhormonal pharmacotherapies that are effective in treating postmenopausal vasomotor symptoms include serotonin–norepinephrine reuptake inhibitors such as desvenlafaxine and venlafaxine. In a recent literature review, these pharmacological treatments were found to be safe, efficacious, and well-tolerated. Approximately 60–80% of menopausal women experience vasomotor symptoms during the initial 7 years of the onset of menopause, which have...

A retrospective study found that the total healthcare costs in menopausal women treated for vasomotor symptoms were moderately greater compared to those of untreated menopausal women  Vasomotor symptoms are the predominant symptoms among menopausal women; however, these mostly remain untreated. While hormone therapy is the commonly administered treatment option, the lack of compliance with this...

A retrospective study reports that dietary supplementation with myo-inositol, cocoa polyphenols, and soy isoflavones positively affects the metabolic profile and vasomotor symptoms of menopausal women with metabolic syndrome. Hormonal changes occurring physiologically during the menopausal transition are associated with an increased risk for metabolic disturbances and vasomotor symptoms. One of the complications of these changes...

While the presence of vasomotor symptoms is associated with low bone mineral density among postmenopausal women, it is not related to an increase in the risk of fractures, according to the findings of a new literature review. Vasomotor symptoms affect the quality of life of postmenopausal women. Other health complications associated with the menopausal transition...

Compared to the general population, the incidence of anxiety in perimenopausal women was relatively greater and was associated with impaired quality of life in perimenopausal women in a questionnaire-based study. Vasomotor symptoms in perimenopausal women have a significant effect on the quality of life of perimenopausal women. In addition to these symptoms, perimenopausal women also...